{"id":5662,"date":"2017-02-23T20:52:57","date_gmt":"2017-02-24T01:52:57","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/pradaxa\/"},"modified":"2022-06-21T16:54:03","modified_gmt":"2022-06-21T20:54:03","slug":"pradaxa","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/fr\/domaines-de-pratique-2\/pradaxa\/","title":{"rendered":"Pradaxa"},"content":{"rendered":"<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">NOUS N&#039;ACCEPTONS PLUS LES CAS PRADAXA<\/h2>\n<p>Les personnes qui souffrent de fibrillation auriculaire peuvent \u00eatre \u00e0 risque de d\u00e9velopper un caillot sanguin, entra\u00eenant un accident vasculaire c\u00e9r\u00e9bral. Pour combattre le risque de caillots sanguins et d&#039;AVC, Pradaxa (dabigatran) emp\u00eache la coagulation des plaquettes dans le sang. Malheureusement, l&#039;anticoagulant a \u00e9galement des effets secondaires graves.<\/p>\n<p>&nbsp;<\/p>\n<h3>Les nombreux effets secondaires dangereux de Pradaxa<\/h3>\n<p>Pradaxa a de nombreux effets secondaires dangereux, dont certains peuvent \u00eatre mortels. Ceux-ci incluent le risque de :<\/p>\n<ul>\n<li>Saignements incontr\u00f4l\u00e9s et graves\u00a0;<\/li>\n<li>H\u00e9morragies c\u00e9r\u00e9brales\u00a0;<\/li>\n<li>Insuffisance h\u00e9patique;<\/li>\n<li>Caillots sanguins spinaux; et<\/li>\n<li>Crise cardiaque.<\/li>\n<\/ul>\n<p>Bien que Pradaxa ait \u00e9t\u00e9 pr\u00e9sent\u00e9 comme une alternative \u00e0 un autre m\u00e9dicament anticoagulant, la warfarine, en raison de sa suppos\u00e9e innocuit\u00e9, il existe <em>Non<\/em> antidote si un patient souffre de saignements incontr\u00f4l\u00e9s pendant qu&#039;il prend Pradaxa (il <em>est<\/em> un antidote aux saignements caus\u00e9s par la warfarine). <a href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM231720.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Selon la FDA<\/a>, le risque de saignement est accru chez les patients \u00e2g\u00e9s de plus de 75 ans, qui ont des probl\u00e8mes r\u00e9naux, un ulc\u00e8re \u00e0 l&#039;estomac ou qui prennent d&#039;autres anticoagulants.<\/p>\n<p>&nbsp;<\/p>\n<h3>D\u00e9p\u00f4t d&#039;un proc\u00e8s Pradaxa<\/h3>\n<p>When a defective drug causes a patient harm, the patient (or the patient\u2019s family) has the right to take legal action directly against the drug\u2019s manufacturer. The manufacturer of Pradaxa is Boehringer Ingelheim, which has already settled a handful of Pradaxa lawsuits and claims. If you believe that you may be eligible to receive a settlement award based on harm that you have suffered as a direct result of taking Pradaxa, you need to consult with an attorney who is experienced in <a class=\"wpil_keyword_link\" href=\"https:\/\/napolilaw.lemonadestand.org\/fr\/domaines-de-pratique-2\/contentieux-pharmaceutique\/\" title=\"contentieux pharmaceutique\" data-wpil-keyword-link=\"linked\" data-wpil-monitor-id=\"68\">contentieux pharmaceutique<\/a> imm\u00e9diatement.<\/p>\n<p>&nbsp;<\/p>\n<h3>Contactez un avocat sp\u00e9cialis\u00e9 dans les drogues d\u00e9fectueuses pr\u00e8s de chez vous d\u00e8s aujourd&#039;hui<\/h3>\n<p>Chez Napoli Shkolnik, PLLC, nos avocats comp\u00e9tents en mati\u00e8re de m\u00e9dicaments d\u00e9fectueux ont des bureaux dans plusieurs \u00c9tats \u00e0 travers les \u00c9tats-Unis, au service des victimes de m\u00e9dicaments d\u00e9fectueux dans tout le pays. Avec des ann\u00e9es d&#039;exp\u00e9rience \u00e0 notre actif, nous savons ce qu&#039;il faut pour gagner une r\u00e9clamation pharmaceutique d\u00e9fectueuse. Pour en savoir plus sur la fa\u00e7on dont nous pouvons vous aider \u00e0 r\u00e9cup\u00e9rer les dommages auxquels vous avez droit, appelez-nous d\u00e8s aujourd&#039;hui pour planifier une consultation.<\/p>","protected":false},"excerpt":{"rendered":"<p>WE ARE NO LONGER ACCEPTING PRADAXA CASES People who suffer from the medical condition atrial fibrillation may be at risk of developing a blood clot, leading to stroke. To combat&#8230;<\/p>","protected":false},"featured_media":0,"menu_order":185,"template":"","practiceareas_category":[743],"class_list":["post-5662","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":1,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5662\/revisions"}],"predecessor-version":[{"id":18250,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas\/5662\/revisions\/18250"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/media?parent=5662"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/fr\/wp-json\/wp\/v2\/practiceareas_category?post=5662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}